Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 234

1.

Endogenous retroviral genes, Herpesviruses and gender in Multiple Sclerosis.

Perron H, Bernard C, Bertrand JB, Lang AB, Popa I, Sanhadji K, Portoukalian J.

J Neurol Sci. 2009 Nov 15;286(1-2):65-72. doi: 10.1016/j.jns.2009.04.034. Epub 2009 May 17. Review.

PMID:
19447411
3.

The human endogenous retrovirus link between genes and environment in multiple sclerosis and in multifactorial diseases associating neuroinflammation.

Perron H, Lang A.

Clin Rev Allergy Immunol. 2010 Aug;39(1):51-61. doi: 10.1007/s12016-009-8170-x. Review.

PMID:
19697163
4.

Analysis of transcribed human endogenous retrovirus W env loci clarifies the origin of multiple sclerosis-associated retrovirus env sequences.

Laufer G, Mayer J, Mueller BF, Mueller-Lantzsch N, Ruprecht K.

Retrovirology. 2009 Apr 15;6:37. doi: 10.1186/1742-4690-6-37.

5.

Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERV-W endogenous retrovirus, but not Human herpesvirus 6.

Mameli G, Astone V, Arru G, Marconi S, Lovato L, Serra C, Sotgiu S, Bonetti B, Dolei A.

J Gen Virol. 2007 Jan;88(Pt 1):264-74.

PMID:
17170460
6.

Molecular cloning and characterization of MSRV-related sequences associated with retrovirus-like particles.

Komurian-Pradel F, Paranhos-Baccala G, Bedin F, Ounanian-Paraz A, Sodoyer M, Ott C, Rajoharison A, Garcia E, Mallet F, Mandrand B, Perron H.

Virology. 1999 Jul 20;260(1):1-9.

7.

The envelope protein of a human endogenous retrovirus-W family activates innate immunity through CD14/TLR4 and promotes Th1-like responses.

Rolland A, Jouvin-Marche E, Viret C, Faure M, Perron H, Marche PN.

J Immunol. 2006 Jun 15;176(12):7636-44.

8.

Correlation between disease severity and in vitro cytokine production mediated by MSRV (multiple sclerosis associated retroviral element) envelope protein in patients with multiple sclerosis.

Rolland A, Jouvin-Marche E, Saresella M, Ferrante P, Cavaretta R, Créange A, Marche P, Perron H.

J Neuroimmunol. 2005 Mar;160(1-2):195-203. Epub 2004 Dec 8.

PMID:
15710473
9.

Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein.

Curtin F, Perron H, Kromminga A, Porchet H, Lang AB.

MAbs. 2015;7(1):265-75. doi: 10.4161/19420862.2014.985021.

10.

Novel reliable real-time PCR for differential detection of MSRVenv and syncytin-1 in RNA and DNA from patients with multiple sclerosis.

Mameli G, Poddighe L, Astone V, Delogu G, Arru G, Sotgiu S, Serra C, Dolei A.

J Virol Methods. 2009 Oct;161(1):98-106. doi: 10.1016/j.jviromet.2009.05.024. Epub 2009 Jun 6.

PMID:
19505508
11.

Endogenous retroviruses and multiple sclerosis. II. HERV-7q.

Alliel PM, Périn JP, Pierig R, Nussbaum JL, Ménard A, Rieger F.

C R Acad Sci III. 1998 Oct;321(10):857-63.

PMID:
9835022
12.

The DNA copy number of human endogenous retrovirus-W (MSRV-type) is increased in multiple sclerosis patients and is influenced by gender and disease severity.

Garcia-Montojo M, Dominguez-Mozo M, Arias-Leal A, Garcia-Martinez Á, De las Heras V, Casanova I, Faucard R, Gehin N, Madeira A, Arroyo R, Curtin F, Alvarez-Lafuente R, Perron H.

PLoS One. 2013;8(1):e53623. doi: 10.1371/journal.pone.0053623. Epub 2013 Jan 7.

13.

Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vbeta16 T-lymphocyte activation.

Perron H, Jouvin-Marche E, Michel M, Ounanian-Paraz A, Camelo S, Dumon A, Jolivet-Reynaud C, Marcel F, Souillet Y, Borel E, Gebuhrer L, Santoro L, Marcel S, Seigneurin JM, Marche PN, Lafon M.

Virology. 2001 Sep 1;287(2):321-32.

14.

MSRV envelope protein is a potent, endogenous and pathogenic agonist of human toll-like receptor 4: Relevance of GNbAC1 in multiple sclerosis treatment.

Madeira A, Burgelin I, Perron H, Curtin F, Lang AB, Faucard R.

J Neuroimmunol. 2016 Feb 15;291:29-38. doi: 10.1016/j.jneuroim.2015.12.006. Epub 2015 Dec 11.

15.
16.

Human endogenous retrovirus W in brain lesions: Rationale for targeted therapy in multiple sclerosis.

van Horssen J, van der Pol S, Nijland P, Amor S, Perron H.

Mult Scler Relat Disord. 2016 Jul;8:11-8. doi: 10.1016/j.msard.2016.04.006. Epub 2016 Apr 22.

17.

Endogenous retrovirus type W GAG and envelope protein antigenemia in serum of schizophrenic patients.

Perron H, Mekaoui L, Bernard C, Veas F, Stefas I, Leboyer M.

Biol Psychiatry. 2008 Dec 15;64(12):1019-23. doi: 10.1016/j.biopsych.2008.06.028. Epub 2008 Aug 29.

PMID:
18760403
18.

An N-terminally truncated envelope protein encoded by a human endogenous retrovirus W locus on chromosome Xq22.3.

Roebke C, Wahl S, Laufer G, Stadelmann C, Sauter M, Mueller-Lantzsch N, Mayer J, Ruprecht K.

Retrovirology. 2010 Aug 24;7:69. doi: 10.1186/1742-4690-7-69.

19.

Molecular cloning and phylogenetic analysis of new human endogenous retrovirus HERV-W family in cancer cells.

Yi JM, Kim HM, Lee WH, Kim HS.

Curr Microbiol. 2002 Mar;44(3):216-20.

PMID:
11821931
20.

Inflammatory response of endothelial cells to a human endogenous retrovirus associated with multiple sclerosis is mediated by TLR4.

Duperray A, Barbe D, Raguenez G, Weksler BB, Romero IA, Couraud PO, Perron H, Marche PN.

Int Immunol. 2015 Nov;27(11):545-53. doi: 10.1093/intimm/dxv025. Epub 2015 May 8.

Supplemental Content

Support Center